CLEAR-AD
Explainable causal AI for early Alzheimer's risk assessment and personalised disease modelling.
Technical approach
Longitudinal MRI, PET, cerebrospinal fluid biomarkers and cognitive assessments are integrated into a multimodal causal pipeline, with personalised counterfactual simulations of patient trajectories.
Clinical relevance
Designed to support earlier diagnosis, disease staging, risk stratification, clinical trial recruitment and explainable multidisciplinary case review.